Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valery Radchenko

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Angewandte Chemie (International Ed. in English)|October 1, 2017
An Eighteen-Membered Macrocyclic Ligand for Actinium-225 Targeted Alpha TherapyNikki A Thiele, Victoria Brown, James M Kelly, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 24, 2021
Production and Supply of α-Particle-Emitting Radionuclides for Targeted α-TherapyValery Radchenko, Alfred Morgenstern, Amir R Jalilian, et al.
Nuclear Medicine and Biology|March 14, 2017
Bulk production and evaluation of high specific activity <sup>186g</sup>Re for cancer therapy using enriched <sup>186</sup>WO<sub>3</sub> targets in a proton beamTara Mastren, Valery Radchenko, Hong T Bach, et al.
Talanta|August 27, 2017
Radiometric evaluation of diglycolamide resins for the chromatographic separation of actinium from fission product lanthanidesValery Radchenko, Tara Mastren, Catherine A L Meyer, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Angewandte Chemie (International Ed. in English)|October 1, 2017
An Eighteen-Membered Macrocyclic Ligand for Actinium-225 Targeted Alpha TherapyNikki A Thiele, Victoria Brown, James M Kelly, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 24, 2021
Production and Supply of α-Particle-Emitting Radionuclides for Targeted α-TherapyValery Radchenko, Alfred Morgenstern, Amir R Jalilian, et al.
Nuclear Medicine and Biology|March 14, 2017
Bulk production and evaluation of high specific activity <sup>186g</sup>Re for cancer therapy using enriched <sup>186</sup>WO<sub>3</sub> targets in a proton beamTara Mastren, Valery Radchenko, Hong T Bach, et al.
Talanta|August 27, 2017
Radiometric evaluation of diglycolamide resins for the chromatographic separation of actinium from fission product lanthanidesValery Radchenko, Tara Mastren, Catherine A L Meyer, et al.
Pageof 8